Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 5.94B | 8.73% |
| Gross profit | profit | 2.63B | 9.31% |
| Cost of revenues | cost | 3.31B | 8.26% |
| Operating income (loss) | profit | 1.10B | 27.14% |
| Total operating expenses | cost | 1.52B | -0.74% |
| Income (loss) before income tax expense (benefit) | profit | 1.05B | 31.54% |
| Other nonoperating income (expense) | revenue | 9.80M | 16.67% |
| Nonoperating income (expense) | revenue | 54.40M | -22.73% |
| Selling, general, and administrative | cost | 1.41B | 5.50% |
| Research and development | cost | 112.90M | 4.93% |
| Restructuring costs | cost | 4.10M | -91.09% |
| Income from continuing operations, net of income tax | profit | 785.10M | 28.37% |
| Income tax expense (benefit) | cost | 262.20M | 41.96% |
| Aggregate | profit | 64.20M | |
| Income from continuing operations, net of income tax | profit | 785.10M | 27.43% |
| Interest expense | cost | 60.70M | -29.66% |
| Other expense (income), net | revenue | 3.50M | -52.70% |
| Net income (loss) attributable to parent | profit | 782.30M | 27.29% |
| Less: net income attributable to noncontrolling interests | cost | 2.80M | 100.00% |
| Segment | Value | YoY |
|---|---|---|
| Healthcare | 4.21B | 8.51% |
| Applied Sterilization Technologies | 1.14B | 9.62% |
| Life Science Member | 588.80M | 8.57% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 4.33B | 8.14% |
| Other foreign locations | 1.49B | 11.09% |
| IRELAND | 108.50M | 1.12% |
| Segment | Value | YoY |
|---|---|---|
| Product | 3.06B | 6.56% |
| Service | 2.88B | 11.12% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable (net of allowances of $24,354 and $22,984, respectively) | assets | 1.09B | 4.67% |
| Inventory, net | assets | 631.80M | 8.69% |
| Cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | assets | 439.60M | 156.03% |
| Prepaid expenses and other current assets | assets | 230.40M | 13.05% |
| Total current assets | assets | 2.39B | 19.68% |
| Goodwill | assets | 4.19B | 2.42% |
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | assets | 2.16B | 10.46% |
| Intangible asset, excluding goodwill, after accumulated amortization | assets | 1.62B | -12.64% |
| Other assets | assets | 211.40M | 154.70% |
| Operating lease, right-of-use asset | assets | 155.20M | -0.77% |
| Assets | assets | 10.74B | 5.82% |
| Stockholders' equity, including portion attributable to noncontrolling interest | liabilities | 7.20B | 8.79% |
| Total liabilities | liabilities | 3.54B | 0.25% |
| Noncontrolling interest | liabilities | 13.60M | 9.68% |
| Accumulated other comprehensive income (loss), net of tax | equity | 113.10M | -61.31% |
| Total shareholders' equity | equity | 7.18B | 8.79% |
| Long-term indebtedness | liabilities | 1.81B | -5.52% |
| Total current liabilities | liabilities | 1.15B | 12.01% |
| Deferred income taxes, net | liabilities | 390.70M | -3.22% |
| Capital lease obligations, noncurrent | liabilities | 119.60M | -4.01% |
| Other liabilities, noncurrent | liabilities | 71.70M | 15.83% |
| Aggregate | equity | 7.30B | 5.82% |
| Accrued expenses and other | liabilities | 401.90M | 9.18% |
| Accounts payable | liabilities | 338.80M | 20.66% |
| Employee-related liabilities, current | liabilities | 221.10M | 14.74% |
| Short-term debt | liabilities | 118.90M | -4.88% |
| Capital lease obligations, current | liabilities | 35.80M | 4.68% |
| Accrued income taxes, current | liabilities | 28.60M | 33.02% |
| Ordinary shares, with $0.001 par value; 500,000 shares authorized; 98,301 and 98,883 ordinary shares issued and outstanding, respectively | equity | 4.28B | -3.16% |
| Retained earnings | equity | 3.02B | 21.84% |
| Item | Value |
|---|---|
| Income from continuing operations, net of income tax | 785.10M |
| Depreciation, depletion and amortization | 486.50M |
| Share-based compensation | 61.70M |
| Increase (decrease) in accounts payable | 51.10M |
| Accruals and other, net | 47.80M |
| Gain (loss) on disposition of property plant equipment | 3.60M |
| Gain (loss) on disposition of business and equity investments, net | -300000 |
| Other noncash income (expense) | -5.60M |
| Deferred income taxes | -16.90M |
| Increase (decrease) in prepaid expense and other assets | -22.70M |
| Increase (decrease) in inventories | -24.00M |
| Increase (decrease) in accounts receivable | -25.10M |
| Item | Value |
|---|---|
| Proceeds from the sale of property, plant, equipment, and intangibles | 10.50M |
| Payments to acquire businesses, net of cash acquired | -20.10M |
| Payments to acquire investments | -134.00M |
| Payments to acquire property, plant, and equipment | -369.00M |
| Item | Value |
|---|---|
| Proceeds from (payment for) other financing activity | 32.90M |
| Proceeds under credit facility, net | 3.00M |
| Payments of merger related costs, financing activities | -400000 |
| Payments to noncontrolling interests | -1.40M |
| Payments for repurchase of private placement | -125.00M |
| Payments for repurchase of common stock | -235.50M |
| Payments of ordinary dividends, common stock | -241.80M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 171.70M |
| Cash and cash equivalents, end of period | 439.60M |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support